OCT 10, 2026 · JOURNAL ARTICLE
CHEK1, TOP2A, and c-MET as potential biomarkers for companion diagnostic development in triple-negative breast cancer
Journal of Advanced Biotechnology and Experimental Therapeutics
Breast cancer is the most diagnosed cancer among women worldwide and represents a major global health burden due to its biological heterogeneity and variable clinical outcomes. Tri